US, WASHINGTON (ORDO NEWS) — Trading on the New York Stock Exchange ended on Thursday with slight fluctuations in key indices. The relevant data is given on the website of this trading platform.
The American industrial index Dow Jones grew by 39.44 points (0.17%) and settled at 23 515.26 points. At the same time, during the trading session, he was gaining more than 300 points, but by the end of the day he fell against the news of the failure of clinical trials of the antiviral drug Remdesivir, which was considered as a possible treatment for the disease caused by a new type of coronavirus.
The S&P 500 index, which includes the 500 largest companies in the US market, lost 1.51 points (0.05%) and was at the level of 2 797,802 points. The Nasdaq Electronic Exchange Index fell 0.63 points (0.01%) to 8,494.75 points. During the trading session, these indices also showed growth, which was lost at the close of markets.
CNBC television company emphasizes that the main reason for this was the news that the drug, developed by the American biopharmaceutical company Gilead Sciences, does not improve the condition of the patient and does not reduce the content of pathogenic microorganisms in the patient’s blood.
At the same time, Gilead Sciences drew attention to the incorrect conditions for conducting clinical trials.
Contact us: firstname.lastname@example.org